RE:RE:RE:Please explainI think you have the wrong lines highlighted here. The statement says "the supply of starting material to registered patients". Starting material to me means clones.
The next line goes on about their intent to sell dried cannabis and oil to their patients under the ACMPR. This would indicate that they are not quite set-up to sell yet in that regard but they WILL BE and are now licensed to. And af far as I know they are the first company to receive their license since the ACMPR was introduced.
It is a bit ambiguos for sure, but this really changes nothing in my opinion. This will be a $2 share this year.
GLTA
FTS (Fak the shorts) lol